Veterinary Pain Management Market Share, Size, Trends, Industry Analysis Report, By Product; By Application; By Animal Type; By End-Use (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores) By Region; Segment Forecast, 2022 - 2030

Veterinary Pain Management Market Share, Size, Trends, Industry Analysis Report, By Product; By Application; By Animal Type; By End-Use (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores) By Region; Segment Forecast, 2022 - 2030

The global veterinary pain management market size is expected to reach USD 2,394.9 million by 2030 according to a new study by Polaris Market Research. The report “Veterinary Pain Management Market Share, Size, Trends, Industry Analysis Report, By Product; By Application; By Animal Type; By End-Use (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores) By Region; Segment Forecast, 2022 – 2030” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Growth in the companion animal population and increasing consumption of meat and milk are the major factors driving the veterinary pain management market’s growth. Additionally, factors such as the growing prevalence of diseases and the increasing number of veterinary practitioners in developed economies are supposed to influence the market’s growth over the forecast period.

One of the main drivers of market expansion is the rising prevalence of acute and chronic diseases in animals worldwide due to numerous reasons. Increasing rates of infectious, deficient, and physiological disorders in animals are having a direct and positive impact on the market’s expansion.

The increasing number of veterinary practitioners across developed countries is another reason responsible for growing the market for veterinary pain management. For instance, veterinary practitioners have increased from 13,539 in 2019 to 118,624 in 2020, according to the American Veterinary Medical Association.

Key players in the market are focusing on implementing strategies such as acquisitions, regional expansions, and mergers, new product launches, partnerships, R&D investments, and distribution agreements to increase their revenue and also bolstering the market. For instance, in December 2018, Antelliq was acquired by Merck for improving its animal vaccines and pharmaceutical portfolio.

Veterinary Pain Management Market Report Highlights

The drug market held the largest market share in 2021 due to the significant use of NSAIDs to control pain and inflammation in animals.

Joint pain applications are anticipated to account for the largest market revenue during the forecast period due to the growing prevalence of osteoarthritis in companion animals.

Livestock animal types are supposed to capture the largest market share in 2021 as chronic diseases are becoming more common and organizations dedicated to animal healthcare are becoming more aware of these issues.

Veterinary hospitals acquired the most significant market revenue in 2021 due to growing investments in expanding veterinary hospitals.

North America dominated the regional market due to growing pet ownership and a growing pool of skilled veterinarians in emerging economies such as the US and Canada.

The global market is highly competitive owing to the existence of large industry players with a global presence including Adisseo, ADM, Assisi Animal Health, BASF SE, Bayer AG, Boehringer Ingelheim International GmbH, Cargill Incorporated, Ceva, Charoen Pokphand Group, Dechra Pharmaceuticals, DSM, DuPont, Elanco, Evonik Industries AG, IDEXX Laboratories, Kemin Industries, Inc., Medtronic, Merck Sharp & Dohme Corp, Norbrook, Novusint, Nutreco, Sumitomo Chemical, Vetoquinol, Virbac, and Zoetis.

Polaris Market Research has segmented the veterinary pain management market report based on product, application, animal type, end-use, and region:

Veterinary Pain Management, Product Outlook (Revenue – USD Million, 2018 – 2030)

Drug Market

By Type

NSAIDS

Opioids

Local anesthetics

Alpha-2 agonists

Disease-modifying osteoarthritis agents

Others

By Route of Administration

Oral

Parenteral

Topical

Devices

Laser Therapy Device

Electromagnetic Device

Veterinary Pain Management, Application Outlook (Revenue – USD Million, 2018 – 2030)

Joint Pain

Osteoarthritis

Musculoskeletal

Cancer Pain

Postoperative Pain

Others

Veterinary Pain Management, Animal Type Outlook (Revenue – USD Million, 2018 – 2030)

Companion Animal

Dog

Cat

Horse

Others

Livestock Animal

Cattle

Swine

Others

Veterinary Pain Management, End-Use Outlook (Revenue – USD Million, 2018 – 2030)

Veterinary Hospitals

Veterinary Clinics

Pharmacies & Drug Stores

Veterinary Pain Management, Regional Outlook (Revenue – USD Million, 2018 – 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa